Analyst Ratings Published by Rodman & Renshaw

11/14/24	Initiated	Buy	X
ACHV Achieve Life Sciences Rodman & Renshaw
$12
11/14/24	Initiated	Buy	X
ADIL Adial Pharmaceuticals Rodman & Renshaw
$8
9/4/24	Downgrades	Buy Neutral	X
ATHA Athira Pharma Rodman & Renshaw
8/19/24	Initiated	Buy	X
ATHA Athira Pharma Rodman & Renshaw
$22
6/12/24	Initiated	Buy	X
AVDL Avadel Pharmaceuticals Rodman & Renshaw
$27
9/27/24	Upgrades	Neutral Buy	X
BMEA Biomea Fusion Rodman & Renshaw
$18
8/22/24	Initiated	Buy	X
DERM Journey Medical Rodman & Renshaw
$9
8/22/24	Initiated	Buy	X
EBS Emergent BioSolutions Rodman & Renshaw
$16
6/13/24	Initiated	Buy	X
HRTX Heron Therapeutics Rodman & Renshaw
$7
1/28/25	Initiated	Buy	X
INDV Indivior Rodman & Renshaw
$16
1/28/25	Initiated	Buy	X
INMB INmune Bio Rodman & Renshaw
$23
8/8/24	Initiated	Buy	X
IPSC Century Therapeutics Rodman & Renshaw
$6
6/28/24	Initiated	Buy	X
LPTX Leap Therapeutics Rodman & Renshaw
$8
8/22/24	Initiated	Buy	X
MIST Milestone Pharmaceuticals Rodman & Renshaw
$9
6/13/24	Initiated	Buy	X
MNKD Mannkind Rodman & Renshaw
$8
10/11/24	Initiated	Buy	X
MNPR Monopar Therapeutics Rodman & Renshaw
$50
6/28/24	Initiated	Buy	X
NKTR Nektar Therapeutics Rodman & Renshaw
$2
10/9/24	Initiated	Buy	X
NKTX Nkarta Rodman & Renshaw
$14
11/14/24	Initiated	Buy	X
OMER Omeros Rodman & Renshaw
$9
9/3/24	Initiated	Buy	X
PASG Passage BIO Rodman & Renshaw
$7
6/13/24	Initiated	Buy	X
RANI Rani Therapeutics Rodman & Renshaw
$10
11/14/24	Initiated	Buy	X
RMTI Rockwell Medical Rodman & Renshaw
$5
6/26/24	Initiated	Buy	X
SANA Sana Biotechnology Rodman & Renshaw
$16
6/13/24	Initiated	Buy	X
TRVI Trevi Therapeutics Rodman & Renshaw
$7
8/22/24	Initiated	Buy	X
UBX Unity Biotechnology Rodman & Renshaw
$8